Review



human ceacam1 elisa kit  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Boster Bio human ceacam1 elisa kit
    Figure 5. Validation of <t>CEACAM1</t> and CRB3 expression in serum EVs. (A) CEACAM1 and CRB3 were detectable by Western blot (WB) analysis (N total = 8). (B) Densitometric quantification of CEACAM1. (C) Densitometric quantification of CRB3. (D) CRB3 was detectable by ELISA analysis. (E) CEACAM1 was detectable by ELISA analysis.* p < 0.05.
    Human Ceacam1 Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ceacam1 elisa kit/product/Boster Bio
    Average 93 stars, based on 2 article reviews
    human ceacam1 elisa kit - by Bioz Stars, 2026-03
    93/100 stars

    Images

    1) Product Images from "Proteomic analysis of serum extracellular vesicles from biliary tract infection patients to identify novel biomarkers."

    Article Title: Proteomic analysis of serum extracellular vesicles from biliary tract infection patients to identify novel biomarkers.

    Journal: Scientific reports

    doi: 10.1038/s41598-024-56036-y

    Figure 5. Validation of CEACAM1 and CRB3 expression in serum EVs. (A) CEACAM1 and CRB3 were detectable by Western blot (WB) analysis (N total = 8). (B) Densitometric quantification of CEACAM1. (C) Densitometric quantification of CRB3. (D) CRB3 was detectable by ELISA analysis. (E) CEACAM1 was detectable by ELISA analysis.* p < 0.05.
    Figure Legend Snippet: Figure 5. Validation of CEACAM1 and CRB3 expression in serum EVs. (A) CEACAM1 and CRB3 were detectable by Western blot (WB) analysis (N total = 8). (B) Densitometric quantification of CEACAM1. (C) Densitometric quantification of CRB3. (D) CRB3 was detectable by ELISA analysis. (E) CEACAM1 was detectable by ELISA analysis.* p < 0.05.

    Techniques Used: Biomarker Discovery, Expressing, Western Blot, Enzyme-linked Immunosorbent Assay



    Similar Products

    human ceacam1 cd66a duoset kit  (R&D Systems)
    94
    R&D Systems human ceacam1 cd66a duoset kit
    Human Ceacam1 Cd66a Duoset Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ceacam1 cd66a duoset kit/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    human ceacam1 cd66a duoset kit - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    human ceacam1 elisa kit  (Boster Bio)
    93
    Boster Bio human ceacam1 elisa kit
    Figure 5. Validation of <t>CEACAM1</t> and CRB3 expression in serum EVs. (A) CEACAM1 and CRB3 were detectable by Western blot (WB) analysis (N total = 8). (B) Densitometric quantification of CEACAM1. (C) Densitometric quantification of CRB3. (D) CRB3 was detectable by ELISA analysis. (E) CEACAM1 was detectable by ELISA analysis.* p < 0.05.
    Human Ceacam1 Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ceacam1 elisa kit/product/Boster Bio
    Average 93 stars, based on 1 article reviews
    human ceacam1 elisa kit - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    csf3r  (Cusabio)
    90
    Cusabio csf3r
    (A) Granulocyte colony-stimulating factor (G-CSF) levels in the bone marrow plasma and peripheral blood plasma of controls and (mean±SD). (B) Colony-stimulating factor receptor <t>(CSF3R)</t> levels in the bone marrow plasma and peripheral blood plasma of control and cirrhosis cases by CTP-A, -B, and -C (mean±SD). (C) Quantitative RT-PCR of colony-stimulating factor receptor 3 ( CSF3R ) mRNA in bone marrow biopsies (mean±SD), n =5 each. (D) Representative images of Immunohistochemistry (IHC) expression of CSF3R in bone marrow biopsies of control and Child-Turcott-Pugh (CTP)-A, B-, C- classes of cirrhosis, all cases. (E) Comparison of baseline colony-stimulating factor receptor (CSFR) levels in bone marrow plasma and peripheral blood plasma of cirrhotic patients with naturally acquired infection during follow-up, and (F) cirrhotic patients who had leukopenia and with normal total leukocyte count, all cases. ** p <0.001, * p =0.001 to <0.05; ns, not-significant.
    Csf3r, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/csf3r/product/Cusabio
    Average 90 stars, based on 1 article reviews
    csf3r - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 5. Validation of CEACAM1 and CRB3 expression in serum EVs. (A) CEACAM1 and CRB3 were detectable by Western blot (WB) analysis (N total = 8). (B) Densitometric quantification of CEACAM1. (C) Densitometric quantification of CRB3. (D) CRB3 was detectable by ELISA analysis. (E) CEACAM1 was detectable by ELISA analysis.* p < 0.05.

    Journal: Scientific reports

    Article Title: Proteomic analysis of serum extracellular vesicles from biliary tract infection patients to identify novel biomarkers.

    doi: 10.1038/s41598-024-56036-y

    Figure Lengend Snippet: Figure 5. Validation of CEACAM1 and CRB3 expression in serum EVs. (A) CEACAM1 and CRB3 were detectable by Western blot (WB) analysis (N total = 8). (B) Densitometric quantification of CEACAM1. (C) Densitometric quantification of CRB3. (D) CRB3 was detectable by ELISA analysis. (E) CEACAM1 was detectable by ELISA analysis.* p < 0.05.

    Article Snippet: Protein levels were determined using ELISA kits according to the manufacturer’s instructions: Human CEACAM1 ELISA Kit (EK1361, BOSTER, China) and Human Protein Crumbs Homolog 3 (CRB3) ELISA Kit (abx386665, abbexa, UK).

    Techniques: Biomarker Discovery, Expressing, Western Blot, Enzyme-linked Immunosorbent Assay

    (A) Granulocyte colony-stimulating factor (G-CSF) levels in the bone marrow plasma and peripheral blood plasma of controls and (mean±SD). (B) Colony-stimulating factor receptor (CSF3R) levels in the bone marrow plasma and peripheral blood plasma of control and cirrhosis cases by CTP-A, -B, and -C (mean±SD). (C) Quantitative RT-PCR of colony-stimulating factor receptor 3 ( CSF3R ) mRNA in bone marrow biopsies (mean±SD), n =5 each. (D) Representative images of Immunohistochemistry (IHC) expression of CSF3R in bone marrow biopsies of control and Child-Turcott-Pugh (CTP)-A, B-, C- classes of cirrhosis, all cases. (E) Comparison of baseline colony-stimulating factor receptor (CSFR) levels in bone marrow plasma and peripheral blood plasma of cirrhotic patients with naturally acquired infection during follow-up, and (F) cirrhotic patients who had leukopenia and with normal total leukocyte count, all cases. ** p <0.001, * p =0.001 to <0.05; ns, not-significant.

    Journal: Journal of Clinical and Translational Hepatology

    Article Title: CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis

    doi: 10.14218/JCTH.2021.00331

    Figure Lengend Snippet: (A) Granulocyte colony-stimulating factor (G-CSF) levels in the bone marrow plasma and peripheral blood plasma of controls and (mean±SD). (B) Colony-stimulating factor receptor (CSF3R) levels in the bone marrow plasma and peripheral blood plasma of control and cirrhosis cases by CTP-A, -B, and -C (mean±SD). (C) Quantitative RT-PCR of colony-stimulating factor receptor 3 ( CSF3R ) mRNA in bone marrow biopsies (mean±SD), n =5 each. (D) Representative images of Immunohistochemistry (IHC) expression of CSF3R in bone marrow biopsies of control and Child-Turcott-Pugh (CTP)-A, B-, C- classes of cirrhosis, all cases. (E) Comparison of baseline colony-stimulating factor receptor (CSFR) levels in bone marrow plasma and peripheral blood plasma of cirrhotic patients with naturally acquired infection during follow-up, and (F) cirrhotic patients who had leukopenia and with normal total leukocyte count, all cases. ** p <0.001, * p =0.001 to <0.05; ns, not-significant.

    Article Snippet: ELSA of human G-CSF (E-EL-H0079) and CSF3R (E-EL-HO799, both from Elabscience, Hubei, China, and CEACAM-1 (CSB-EL005157HU, Cusabio, Hubei, China) were performed on BM and peripheral blood (PB) plasma from cirrhosis patients and control participants.

    Techniques: Quantitative RT-PCR, Immunohistochemistry, Expressing, Infection

    (A) Area under the curve of circulatory colony-stimulating factor receptor (CSF3R) level in peripheral blood for neutropenia and (B) infection. (C) Baseline Colony-stimulating factor receptor (CSF3R) in peripheral blood plasma from the original cohort ( n =15) and (D) Validation cohort ( n =22) of cirrhosis patients who responded to granulocyte- colony stimulating factor (GCSF) treatment for neutropenia vs. nonresponders {median, interquartile range (IQR) }. ** p <0.001, * p =0.001 to <0.05; ns, not significant.

    Journal: Journal of Clinical and Translational Hepatology

    Article Title: CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis

    doi: 10.14218/JCTH.2021.00331

    Figure Lengend Snippet: (A) Area under the curve of circulatory colony-stimulating factor receptor (CSF3R) level in peripheral blood for neutropenia and (B) infection. (C) Baseline Colony-stimulating factor receptor (CSF3R) in peripheral blood plasma from the original cohort ( n =15) and (D) Validation cohort ( n =22) of cirrhosis patients who responded to granulocyte- colony stimulating factor (GCSF) treatment for neutropenia vs. nonresponders {median, interquartile range (IQR) }. ** p <0.001, * p =0.001 to <0.05; ns, not significant.

    Article Snippet: ELSA of human G-CSF (E-EL-H0079) and CSF3R (E-EL-HO799, both from Elabscience, Hubei, China, and CEACAM-1 (CSB-EL005157HU, Cusabio, Hubei, China) were performed on BM and peripheral blood (PB) plasma from cirrhosis patients and control participants.

    Techniques: Infection

    (A) Representative images of flow cytometry of bone marrow aspirates with acquired CD34+ cells (%) and CSF3R+CD34+ cells (%) in control and cirrhosis Child-Turcott-Pugh (CTP) classes A,B,C), n =25 each. (B) Distribution of CD34+ cells % in control and cirrhosis (CTP classes A, B, C), median, interquartile range (IQR), n =25 each. (C) Distribution of CSF3R+CD34+ (%) of total bone marrow C34+ cells, median (interquartile range), n =25 each. (D) Distribution of granulocyte monocyte-colony forming unit (GM-CFU) and burst forming unit-erythroid (BFU-E) across the study groups, median (interquartile range), n =10 each. ** p <0.001, * p =0.001 to <0.05; ns, not significant.

    Journal: Journal of Clinical and Translational Hepatology

    Article Title: CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis

    doi: 10.14218/JCTH.2021.00331

    Figure Lengend Snippet: (A) Representative images of flow cytometry of bone marrow aspirates with acquired CD34+ cells (%) and CSF3R+CD34+ cells (%) in control and cirrhosis Child-Turcott-Pugh (CTP) classes A,B,C), n =25 each. (B) Distribution of CD34+ cells % in control and cirrhosis (CTP classes A, B, C), median, interquartile range (IQR), n =25 each. (C) Distribution of CSF3R+CD34+ (%) of total bone marrow C34+ cells, median (interquartile range), n =25 each. (D) Distribution of granulocyte monocyte-colony forming unit (GM-CFU) and burst forming unit-erythroid (BFU-E) across the study groups, median (interquartile range), n =10 each. ** p <0.001, * p =0.001 to <0.05; ns, not significant.

    Article Snippet: ELSA of human G-CSF (E-EL-H0079) and CSF3R (E-EL-HO799, both from Elabscience, Hubei, China, and CEACAM-1 (CSB-EL005157HU, Cusabio, Hubei, China) were performed on BM and peripheral blood (PB) plasma from cirrhosis patients and control participants.

    Techniques: Flow Cytometry

    (A) mRNA expression of, carcinoembryonic antigen cell adhesion molecule-1 ( CEACAM-1) gene in the bone marrow biopsies of control and cirrhosis classes (mean±SD), n =5. (B) Representative images and graphical representation of CEACAM-1+ bone marrow cells in control and cirrhosis classes (20×). (C) Graphical representation of CEACAM-1 in bone marrow plasma (mean±SD). (D) CEACAM-1 levels in the peripheral blood plasma of control and cirrhosis classes (mean±SD), and (E) representative images of flow cytometry of bone marrow mononuclear cultured cells display the difference in CD34+CSF3R+ cells without CEACAM-1 and with CEACAM-1 treatment for 24 h, n =5. ** p <0.001, * p =0.001 to <0.05; ns, not significant.

    Journal: Journal of Clinical and Translational Hepatology

    Article Title: CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis

    doi: 10.14218/JCTH.2021.00331

    Figure Lengend Snippet: (A) mRNA expression of, carcinoembryonic antigen cell adhesion molecule-1 ( CEACAM-1) gene in the bone marrow biopsies of control and cirrhosis classes (mean±SD), n =5. (B) Representative images and graphical representation of CEACAM-1+ bone marrow cells in control and cirrhosis classes (20×). (C) Graphical representation of CEACAM-1 in bone marrow plasma (mean±SD). (D) CEACAM-1 levels in the peripheral blood plasma of control and cirrhosis classes (mean±SD), and (E) representative images of flow cytometry of bone marrow mononuclear cultured cells display the difference in CD34+CSF3R+ cells without CEACAM-1 and with CEACAM-1 treatment for 24 h, n =5. ** p <0.001, * p =0.001 to <0.05; ns, not significant.

    Article Snippet: ELSA of human G-CSF (E-EL-H0079) and CSF3R (E-EL-HO799, both from Elabscience, Hubei, China, and CEACAM-1 (CSB-EL005157HU, Cusabio, Hubei, China) were performed on BM and peripheral blood (PB) plasma from cirrhosis patients and control participants.

    Techniques: Expressing, Flow Cytometry, Cell Culture

    (A) C-X-C chemokine receptor type 4 (CXCR4+) cells in cytospin smears of sorted CD34 cells from bone marrow in the control and cirrhosis classes (Giemsa, 20×), and (B) Graph of distribution, median (interquartile range), n =10 each. (C) Distribution of CSF3R−TLR3+ CD34 cells, and (D) CSF3R+TLR3− CD34 cells in control and cirrhotic classes, median (interquartile range), n =25 each. (E) Representative images of ubiquitin-positive cells/20 fields in the bone marrow of study groups (20×) and (F) graphical representation of the cells across the study groups, median (interquartile range), all cases. ** p <0.001, * p =0.001 to <0.05; ns, not significant.

    Journal: Journal of Clinical and Translational Hepatology

    Article Title: CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis

    doi: 10.14218/JCTH.2021.00331

    Figure Lengend Snippet: (A) C-X-C chemokine receptor type 4 (CXCR4+) cells in cytospin smears of sorted CD34 cells from bone marrow in the control and cirrhosis classes (Giemsa, 20×), and (B) Graph of distribution, median (interquartile range), n =10 each. (C) Distribution of CSF3R−TLR3+ CD34 cells, and (D) CSF3R+TLR3− CD34 cells in control and cirrhotic classes, median (interquartile range), n =25 each. (E) Representative images of ubiquitin-positive cells/20 fields in the bone marrow of study groups (20×) and (F) graphical representation of the cells across the study groups, median (interquartile range), all cases. ** p <0.001, * p =0.001 to <0.05; ns, not significant.

    Article Snippet: ELSA of human G-CSF (E-EL-H0079) and CSF3R (E-EL-HO799, both from Elabscience, Hubei, China, and CEACAM-1 (CSB-EL005157HU, Cusabio, Hubei, China) were performed on BM and peripheral blood (PB) plasma from cirrhosis patients and control participants.

    Techniques: